Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer

Author： Lønning Per Eystein   Geisler Jürgen  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.7, 2008-07, pp. : 987-997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exemestane in postmenopausal women with early or advanced breast cancer: a review

By Bertelli Gianfilippo   Gangadhara Sharath  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1933-1942

Informa Healthcare

Access to resources Recommend Favorite

Fulvestrant as EFECTive as exemestane in advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Exemestane and aromatase inhibitors in the management of advanced breast cancer

By Dixon J Michael  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 307-316

Informa Healthcare

Access to resources Recommend Favorite

Switch to exemestane beneficial in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Tamoxifen + exemestane preferred in early breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite